Evidence map›Paper›PMID 40186821›Full record

ArticleEsophagus : official journal of the Japan Esophageal Society2025

Post-endoscopy esophageal squamous cell carcinoma with invasion of the muscularis mucosa or deeper detected in surveillance endoscopy after esophageal endoscopic resection.

Daiki Kitagawa, Ryu Ishihara, Shunsuke Yoshii, Yuya Asada, Tomoya Ueda, Atsuko Kizawa, Takehiro Ninomiya, Yuki Okubo, Yushi Kawakami, Yasuhiro Tani and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Esophagus : official journal of the Japan Esophageal Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Daiki KitagawaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Ryu IshiharaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan. ryu1486@gmail.com.ORCID 0000-0002-8796-718X
Shunsuke YoshiiDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Yuya AsadaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Tomoya UedaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Atsuko KizawaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Takehiro NinomiyaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Yuki OkuboDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Yushi KawakamiDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Yasuhiro TaniDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Minoru KatoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Satoki ShichijoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Takashi KanesakaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Sachiko YamamotoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Yoji TakeuchiDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Koji HigashinoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Noriya UedoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Tomoki MichidaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Yasuhiro FujiwaraDepartment of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurveillance endoscopy is recommended after endoscopic resection of esophageal squamous cell carcinomas (ESCCs). However, surveillance endoscopy sometimes detects advanced subsequent ESCCs with invasion of the muscularis mucosa (MM) or deeper. We aimed to clarify the clinicopathological features of these advanced subsequent ESCCs.

methodsThis single-center retrospective study identified subsequent ESCCs detected during surveillance endoscopy. ESCCs that invaded the MM or deeper and were detected within 24 months after the previous endoscopy were defined as post-endoscopy esophageal advanced lesions (PEEALs), while the first ESCC detected in the patient was defined as the primary lesion. Study 1 compared the clinicopathological characteristics of PEEALs versus non-advanced lesions. Study 2 compared the endoscopic features of pT1a-MM PEEALs versus pT1a-MM primary lesions.

resultsA total of 307 subsequent ESCCs were analyzed in Study 1. Of these, 20 were PEEALs and 287 were non-advanced lesions (pT1a-EP/LPM). The median intervals from the previous endoscopy for PEEALs and non-advanced lesions were 6.1 months and 6.7 months, respectively (P = 0.283). The morphological feature of marginal elevation was seen in 60% of PEEALs. In Study 2, 15 pT1a-MM PEEALs were compared with 149 pT1a-MM primary lesions. Compared with primary lesions, pT1a-MM PEEALs were smaller (median 10 mm vs. 30 mm, P < 0.001) and had a higher prevalence of marginal elevation morphology (53.3% vs. 10.1%, P < 0.001).

conclusionsThe specific feature of PEEALs was marginal elevation. Surveillance endoscopy with careful observation for these lesions is recommended after endoscopic resection of ESCCs.

Indexed as

Esophageal MucosaEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaEsophagoscopyAgedEsophagectomyFemaleHumansMaleMiddle AgedMucous MembraneNeoplasm InvasivenessRetrospective StudiesDiagnostic techniquesDigestive systemEndoscopyEsophageal neoplasmsEsophageal squamous cell carcinomaGastrointestinal

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.